Storage stability of bevacizumab in polycarbonate and polypropylene syringes
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://www.nature.com/articles/eye201528.pdf
Reference34 articles.
1. Ahfat FG, Zaidi FH . Bevacizumab vs ranibizumab-an appraisal of the evidence from CATT and IVAN. Eye 2013; 27 (3): 289–290.
2. Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Wordsworth S et al. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology 2012; 119 (7): 1399–1411.
3. Martin DF, Maguire MG, Fine SL, Ying G, Jaffe GJ, Grunwald JE et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 2012; 119 (7): 1388–1398.
4. Guttman C . CATT and IVAN results. Retina 2012; 17: 9.
5. Ferrara N . Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy. Nat Med 2010; 16 (10): 1107–1111.
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration;Ophthalmology and Therapy;2023-01-06
2. Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials;European Journal of Hospital Pharmacy;2022-07-19
3. The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration;Scientific Reports;2022-02-22
4. Synthesis and characterization of substrates for grafting polymers used in medical plastics;Chemical Data Collections;2021-02
5. Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections;Progress in Retinal and Eye Research;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3